Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venus Association in Vulvovaginal Candidiasis
NCT05031481Phase 2Withdrawn
- Sponsor
- EMS
- Start
- Jul 2022
- Primary completion
- Dec 2023
01
Overview
Phase 2, randomised, double-blind trial in vulvovaginal candidiasis (VVC) (4 arms), sponsored by EMS. Primary endpoint: Time to first relief of symptoms. Planned start Jul 2022; status: withdrawn.
02
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT05031481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05031481.